UK markets closed

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9800+0.0401 (+4.27%)
At close: 04:00PM EDT
0.9600 -0.02 (-2.04%)
After hours: 07:48PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-51,919
-17,311
-18,504
-48,977
-6,865
Depreciation & amortisation
542.035
408.03
435.201
681.612
120.872
Deferred income taxes
0
0
-1,504
-7,455
0
Stock-based compensation
9,859
2,150
2,621
12,597
1,977
Change in working capital
-716.92
-174.75
-217.66
1,185
-369.495
Other working capital
-18,520
-14,100
-17,731
-12,322
-3,933
Other non-cash items
1,848
1,848
-
1,159
1,247
Net cash provided by operating activities
-17,752
-14,094
-17,147
-11,458
-3,889
Cash flows from investing activities
Investments in property, plant and equipment
-767.691
-5.18
-584.165
-864.719
-44.143
Net cash used for investing activities
-767.69
11.667
-584.165
2,191
-44.143
Cash flows from financing activities
Debt repayment
-
-
-
0
-191.64
Common stock issued
17,222
0
17,222
21,614
488
Common stock repurchased
-1,052
-1,052
-
-
-
Other financing activities
-291.084
-291.084
958.038
-
3,373
Net cash used provided by (used for) financing activities
18,180
-1,343
18,180
24,900
5,531
Net change in cash
-247.421
-15,436
367.885
15,778
1,535
Cash at beginning of period
21,448
17,724
17,356
1,578
43.714
Cash at end of period
21,109
2,288
17,724
17,356
1,578
Free cash flow
Operating cash flow
-17,752
-14,094
-17,147
-11,458
-3,889
Capital expenditure
-767.691
-5.18
-584.165
-864.719
-44.143
Free cash flow
-18,520
-14,100
-17,731
-12,322
-3,933